Target intelligence / Profile preview

Parasitic serine protease

Molecular classification
Enzyme, Hydrolase, Serine protease
01

Overview

Parasitic serine proteases are a diverse group of enzymes characterized by a nucleophilic serine residue in their active site, playing indispensable roles in the life cycles of various protozoa and helminths [1, 3]. These enzymes facilitate critical processes such as host tissue penetration, nutrient acquisition through the degradation of host proteins, and the evasion of the host's immune system [3, 5]. In malaria-causing Plasmodium species, subtilisin-like proteases (e.g., PfSUB1) are essential for the egress of merozoites from infected erythrocytes and the subsequent invasion of new red blood cells [2, 4]. Because these proteases often have distinct substrate specificities compared to their human counterparts, they are highly attractive targets for the development of selective antiparasitic agents [1, 5]. Inhibiting these enzymes can effectively halt parasite replication and spread within the host. However, achieving high selectivity is crucial to avoid interfering with vital human serine proteases involved in blood clotting and digestion [1, 7]. Current research focuses on identifying unique structural features of parasite proteases to design potent, small-molecule inhibitors with minimal host toxicity [5].

Other names
Helminth serine proteaseProtozoan serine proteaseSubtilisin-like proteaseChymotrypsin-like proteaseParasite-derived serine peptidasePlasmodium falciparum subtilisin-like protease 1 (PfSUB1)Rhomboid protease
02

Mechanism of action

Inhibition of the catalytic serine residue within the active site, typically involving a Ser-His-Asp catalytic triad, which prevents the cleavage of peptide bonds in essential parasite or host proteins required for the parasite's life cycle, invasion, or egress [1, 2].

03

Biological functions

ProteolysisHost cell invasionParasite egressNutrient acquisitionImmune evasionTissue degradation
04

Disease associations

InfectionMalariaSchistosomiasisToxoplasmosisLeishmaniasisTrypanosomiasis
05

Safety considerations

Off-target inhibition of human serine proteases (e.g., thrombin, trypsin, plasmin) [1, 7]Coagulopathy or bleeding risks [7]Gastrointestinal distressPotential for allergic reactions
06

Interacting drugs

Nafamostat [1]

5 more in the full profile.

07

Biomarkers

Parasite-specific protease activity [4]Circulating Anodic Antigen (CAA) [5]PfSUB1 antigen levels [4, 6]Protease-specific antibodies

Beyond the preview

Go deeper on Parasitic serine protease.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parasitic serine protease.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call